@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:be . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:06.571263"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "an evolving area" . rdf:OBJECT-POSITION rdfs:label "(4, 19)" . rdf:PREDICATE rdfs:label "is" . rdf:PREDICATE-POSITION rdfs:label "101, 103" . rdf:SUBJECT rdfs:label "The pharmacotherapy of Takayasu arteritis ( TAK ) with disease-modifying anti-rheumatic drugs ( DMARDs )" . rdf:SUBJECT-POSITION rdfs:label "(4, 19)" . rdf:Statement rdfs:label "The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area." . rdfs:ABSTRACT-UID ns3:50 "fcy3fn4c" . rdfs:TRIPLE-UID ns2:fcy3fn4c-TRIPLE-ABSTRACT-2 "fcy3fn4c-TRIPLE-ABSTRACT-2" . rdfs:label "pharmacotherapy" . rdfs:label "area" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }